All Articles

Beijing is doubling down on esports, hosting major tournaments and investing heavily in the industry. Is this a genuine push for innovation, or a strategic play to enhance China’s global influence and connect with a new generation?

Pulsar Helium’s Topaz project in Minnesota is advancing, with promising results for both helium supply and the potential extraction of valuable helium-3, positioning the state as a key player in critical resource development.

NB Private Equity Partners' recent share repurchase program, coupled with robust financial results, highlights a strategic commitment to shareholder value within a dynamic private equity landscape. Analysts explore the move's implications.

A national initiative is collecting used tech from Canadian businesses to empower charities and reduce e-waste, addressing critical needs and fostering sustainability.

New metrology system leverages wavefront phase imaging for sub-nanometer resolution and ultra-fast measurement, addressing critical needs in advanced semiconductor production. Backed by major industry investors.

Positive assay results and a large geophysical anomaly signal promising prospects for Pan Global Resources' Cañada Honda target in Spain's mineral-rich Iberian Pyrite Belt, bolstering Europe's critical mineral supply chain.

Biotech firm Invivyd secures $125 million to advance its VYD2311 antibody, targeting evolving COVID-19 variants and offering potential solutions for Long COVID. Is this funding a sign of confidence or a risky bet?

US Auto Trust's acquisition of Czinger Dallas gains momentum with delivery of a bespoke hypercar. Czinger’s innovative AI and 3D printing technologies are redefining performance and manufacturing.

Positive trial data suggests Vanda Pharmaceuticals’ tradipitant could address a major barrier to GLP-1 adherence – nausea and vomiting – potentially expanding access to these increasingly popular medications.

As the drone delivery industry matures, one company is aggressively consolidating intellectual property. Valqari’s acquisition of Skydrop’s patents signals a new era of potential market dominance – and raises questions about innovation and competition.

The lumber and building materials manufacturer is renewing its share repurchase program, suggesting optimism despite cooling housing trends. Experts weigh in on the company's financial health and industry outlook.

Fennec Pharmaceuticals secured $40.25 million in a public offering to advance its lead product, PEDMARK, which aims to reduce ototoxicity in cancer patients. The funding will also address debt and bolster working capital.

Highwoods Properties' $223M acquisition of 6Hundred at Legacy Union signals a strategic shift in Charlotte’s office market, emphasizing quality and long-term stability amid evolving work trends.

Apyx Medical Corporation announced a planned stock offering as it capitalizes on rising demand for minimally invasive body contouring procedures. The company’s recent financial performance and strategic expansion plans support the move.

Biopharma firm Invivyd secured $125 million in a public offering, fueling commercialization of its novel antibody, VYD2311, and expansion into RSV and measles treatments. Analysts question if the funding is enough.

Regional lender Middlefield Banc Corp. announces a steady dividend, bolstered by strong Q3 performance and strategic lending in Ohio. Analysts see continued stability amidst a changing economic landscape.

Years after falling into disrepair, the home where Nina Simone spent her formative years has been meticulously restored, becoming a powerful symbol of artistic heritage and a beacon of cultural preservation.

Michigan-based financial services company Credit Acceptance Corporation maintains its position as a leading employer, lauded for its commitment to remote work and employee wellbeing.

Walnut Creek-based Golden State Dermatology is doubling down on growth, leveraging digital pathology and a consolidation strategy to expand its reach and address evolving healthcare needs.

A pending regulatory order involving CNSX Markets Inc. and an individual raises questions about oversight of smaller exchanges and potential risks for investors. The OSC is intensifying focus on compliance.